Heart failure patients have had pressure sensors in their lungs for a decade. Nothing was ever wrong with the device.
The problem is utilization - what the clinic does what the number varies wildly by provider, day, and institution.
SMART-HF fixes that. π¨βπ§
Those targets aren't arbitrary. Two large analyzes independently tie them to survival - reaching target = HR 0.72; a greater than 2 mmHg drop ~ 15% lower 2-yr mortality.
SMART-HF is the missing instruction manual for a tool thousands of clinics already deploy.
The comparison that matters: among patients who started with high pressures, SMART-HF got roughly twice as many to a survival-linked target as real-world Medicare management -- 47% vs 24%.
Mean drop -3.3 mmHg ~double real-world care.
37-patient community cohort.
Mean PA diastolic pressure fell 18.3 -> 16.1 mmHg at 90 days and 18.8 -> 15.5 mmHg at 6 months (both p< 0.001).
And the effect got bigger at 6-months, not smaller. The structure keeps working past the early post implant window.
In a recent @Cardiacwire interview, general #Cardiologist Dr. @AtzenhoeferM shares how our CardioMEMS HF System helps him proactively monitor PA pressures for his patients.
Traditional #HeartFailure management reacts to symptoms β #CardioMEMS helps change that.
Watch now: https://t.co/xSilDgHoWl
US Safety Info: https://t.co/wAqIuUd269
Entrenched practice patterns. Beware usual heart failure metrics in this population. Incorporating weights, symptoms, and exam findings into decision making complicates management, increases hospitalizations, and blunts the advantages afforded by implantable PA pressure sensors.
https://t.co/IBNVtCvk3L
Heart failure patients transmitting remote pulmonary artery pressures fare better when strictly managed by hemodynamic algorithm. Routine care guided by algorithm ensures hemodynamic triggers for intervention while simultaneously curbing